Revolution Medicines, Inc. (RVMD) Free cash flow 2018–2025
Revolution Medicines, Inc. (RVMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$913.7MFY2025 · since FY2018: -$286,000 → -$913.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$913.7M | -60.9% |
| FY2024 | -$567.7M | -58.5% |
| FY2023 | -$358.3M | -52.3% |
| FY2022 | -$235.2M | -53.0% |
| FY2021 | -$153.7M | -49.2% |
| FY2020 | -$103.0M | -97.3% |
| FY2019 | -$52.2M | -18153.5% |
| FY2018 | -$286,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net incomeRVMD Net marginRVMD Gross profitRVMD Gross marginRVMD Operating incomeRVMD Operating marginRVMD Operating cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Total liabilitiesRVMD Shareholders’ equityRVMD overview →